Literature DB >> 376556

Interference with the mannose binding and epithelial cell adherence of Escherichia coli by sublethal concentrations of streptomycin.

B I Eisenstein, I Ofek, E H Beachey.   

Abstract

When Escherichia coli was grown in sublethal concentrations of streptomycin, mannose binding activity and epithelial cell adherence of the E. coli cultures at stationary phase were significantly reduced in the drug-grown organisms. In a strain whose minimal inhibitory concentrations was 30 mug/ml, the percentage of reduction in mannose binding activity was dose related over a range of concentrations between 0.5 and 10 mug/ml streptomycin. Concomitant with the drug-induced suppression of mannose binding activity, antigenic and ultrastructural alterations on the surface of the drug-grown organisms were observed by agglutination tests and electron microscopy, respectively. The streptomycin effect was reversible, required actively growing organisms, and was most apparent in the early log-phase of growth. High doses of antibiotic were ineffective when added to cultures which had acquired mannose binding activity. An isogenic derivative with high-level resistance to streptomycin was obtained as a single-step mutation from the test E. coli strain. Whereas the isogenic mutant possessed mannose binding activity and adhering ability similar to the parent strain, it was resistant to the streptomycin-induced suppression of the two activities at enormous concentrations (up to 10,000 mug/ml) of streptomycin. Taken together the results suggest that the suppression of epithelial cell adherence and mannose binding activity of E. coli grown in sublethal concentrations of streptomycin is a result of classic mechanisms of drug action upon the bacterial ribosome. The results support the possibility that antibiotics may act through mechanisms other than inhibition of growth and bacterial killing to eradicate bacteria from mucosal surfaces.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 376556      PMCID: PMC372071          DOI: 10.1172/JCI109417

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  15 in total

1.  STREPTOMYCIN-INDUCED OVERSUPPRESSION IN E. COLI.

Authors:  L GORINI; E KATAJA
Journal:  Proc Natl Acad Sci U S A       Date:  1964-06       Impact factor: 11.205

2.  STREPTOMYCIN, SUPPRESSION, AND THE CODE.

Authors:  J DAVIES; W GILBERT; L GORINI
Journal:  Proc Natl Acad Sci U S A       Date:  1964-05       Impact factor: 11.205

3.  The hydrolysis of rabbit y-globulin and antibodies with crystalline papain.

Authors:  R R PORTER
Journal:  Biochem J       Date:  1959-09       Impact factor: 3.857

4.  Adherence of Escherichia coli to human mucosal cells mediated by mannose receptors.

Authors:  I Ofek; D Mirelman; N Sharon
Journal:  Nature       Date:  1977-02-17       Impact factor: 49.962

5.  Identification and functional characterization of the protein controlled by the streptomycin-resistant locus in E. coli.

Authors:  M Ozaki; S Mizushima; M Nomura
Journal:  Nature       Date:  1969-04-26       Impact factor: 49.962

6.  Effects of 5-hydroxytryptamine on platelet aggregation.

Authors:  H R Baumgartner; G V Born
Journal:  Nature       Date:  1968-04-13       Impact factor: 49.962

7.  Cell wall alterations of gram-negative bacteria by aminoglycoside antibiotics.

Authors:  K Iida; M Koike
Journal:  Antimicrob Agents Chemother       Date:  1974-01       Impact factor: 5.191

8.  Resistance of Neisseria gonorrhoeae to phagocytosis: relationship to colonial morphology and surface pili.

Authors:  I Ofek; E H Beachey; A L Bisno
Journal:  J Infect Dis       Date:  1974-03       Impact factor: 5.226

9.  Mannose binding and epithelial cell adherence of Escherichia coli.

Authors:  I Ofek; E H Beachey
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

10.  Hemagglutination by purified type I Escherichia coli pili.

Authors:  I E Salit; E C Gotschlich
Journal:  J Exp Med       Date:  1977-11-01       Impact factor: 14.307

View more
  22 in total

1.  Genetic control of flocculation in Escherichia coli.

Authors:  K L Ogden; A L Taylor
Journal:  J Ind Microbiol       Date:  1991-06

Review 2.  Bacterial adhesion: modulation by antibiotics which perturb protein synthesis.

Authors:  D M Schifferli; E H Beachey
Journal:  Antimicrob Agents Chemother       Date:  1988-11       Impact factor: 5.191

Review 3.  Nosocomial pneumonia in patients in intensive care units.

Authors:  S D Podnos; G B Toews; A K Pierce
Journal:  West J Med       Date:  1985-11

4.  Operon fusion of the phase variation switch. A virulence factor in Escherichia coli.

Authors:  B I Eisenstein
Journal:  Infection       Date:  1982       Impact factor: 3.553

5.  Pseudocatabolite repression of type 1 fimbriae of Escherichia coli.

Authors:  B I Eisenstein; D C Dodd
Journal:  J Bacteriol       Date:  1982-09       Impact factor: 3.490

6.  Loss of lectin-like activity in aberrant type 1 fimbriae of Escherichia coli.

Authors:  B I Eisenstein; I Ofek; E H Beachey
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

7.  Attachment of bacteria to mammalian surfaces.

Authors:  B Sugarman
Journal:  Infection       Date:  1980       Impact factor: 3.553

8.  Mannose-specific adherence of Escherichia coli freshly excreted in the urine of patients with urinary tract infections, and of isolates subcultured from the infected urine.

Authors:  I Ofek; A Mosek; N Sharon
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

9.  Increased phagocytosis and killing of Escherichia coli treated with subinhibitory concentrations of cefamandole and gentamicin in isolated rat livers.

Authors:  A Andreana; P Perna; R Utili; M Dilillo; G Ruggiero
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

10.  Interaction of beta-lactam antibiotics with the bactericidal activity of leukocytes against Escherichia coli.

Authors:  A Dalhoff
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.